Officially Idera is about to acquire Embarcadero this week after final agreements are made. Idera press release provides you with some additional information concerning the purchase. At this moment no one really knows what this means for the Rad Studio product as well the other database packages that Embarcadero sells nor what will happen with the company name.
At this point the Embarcadero staff members are pretty happy and developers will have to wait until something is provided by Idera. Usually in purchases older products that have no relevance are stopped and particular development sites are dropped to condense the groups. and finally Idera managers take over after the internal review of what is happening.
Some things that can changed in the next year or so:
- EDN (Embarcadero Developers Network) which provides the product updates needs a serious remake.
- Product pricing will that remain stable, decrease or increase ?
- With over 3 million world wide developers what will happen with the VCL version for Window development ? Will Firemonkey become the dominate software tool ?
- The database powerstudio software tools will that be merged with the Idera SQL product lines ?
- HTML 5 Builder will that be discontinued, it seems nothing has been done with the product since XE5
- What will happen with the Embarcadero name, will that disappear or be a jointed name for a period of time.
- When will the company chart of board members be released ?
These are just some of the questions that are being asked and there are numerous others so stay tuned.
Dr. Alexander Epelbaum Appointed President of the Medical Staff at St. Catherine of Siena
by Stephanie Cella on December 12, 2017 at 6:23 pm
Dr. Alexander Epelbaum of Dix Hills, a urologist at Advanced Urology Centers of New York in Smithtown, has been appointed president of the medical staff at St. Catherine of Siena Medical Center in Smithtown. See the Newsday article here. […]
A Bill to ‘Eliminate Prostate Cancer Misdiagnosis’
by Stephanie Cella on November 21, 2017 at 6:13 pm
More than 1 million prostate biopsies are performed in the U.S. each year. Provenance errors (i.e. switching and contamination) in prostate cancer diagnosis occurs at a rate of 1.28%. Deepak A. Kapoor, MD and colleagues feel that the DNA test … Continue reading &rarr […]